Cargando…

Is There a Sweet Spot for Nrf2 Activation in the Treatment of Diabetic Kidney Disease?

Detalles Bibliográficos
Autores principales:	Hall, Evan T., Bhalla, Vivek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2014
Materias:	Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4141365/ https://www.ncbi.nlm.nih.gov/pubmed/25146471 http://dx.doi.org/10.2337/db14-0829

Ejemplares similares

Basal insulin delivery reduction for exercise in type 1 diabetes: finding the sweet spot
por: Thabit, Hood, et al.
Publicado: (2016)

A Transcriptional Blueprint for Human and Murine Diabetic Kidney Disease
por: Bhalla, Vivek, et al.
Publicado: (2013)

How Sweet It Is: Intestinal Sweet Taste Receptors in Type 2 Diabetes
por: Greenfield, Jerry R., et al.
Publicado: (2013)

Resistance to ERK1/2 pathway inhibitors; sweet spots, fitness deficits and drug addiction
por: Sale, Matthew J., et al.
Publicado: (2019)

Protective Effect of Nrf2 and Catalase in Maternal Diabetes-Induced Perinatal Hypertension and Kidney Disease
por: Vaziri, Nosratola D.
Publicado: (2012)

Nrf2 Activators as Attractive Therapeutics for Diabetic Nephropathy
por: de Haan, Judy B.
Publicado: (2011)

Finding the Sweet Spot: How Human Fungal Pathogens Acquire and Turn the Sugar Inositol against Their Hosts
por: Xue, Chaoyang
Publicado: (2015)

Finding the Sweet Spot: Measurement, Modification, and Application of Sweet Hedonics in Humans
por: Cheon, Eunjin, et al.
Publicado: (2021)

Proximal Tubular Secretion: A New Way to Assess for Kidney Dysfunction?
por: Au, Eric H.K., et al.
Publicado: (2022)

Salt: the sweet spot?( )
por: Rosengren, Annika
Publicado: (2022)

Group B Streptococcus and diabetes: Finding the sweet spot
por: Keogh, Rebecca A., et al.
Publicado: (2023)

Oligometastatic Disease Management: Finding the Sweet Spot
por: Szturz, Petr, et al.
Publicado: (2020)

The Missing Link: Studying the Alternative TGF-β Pathway Provides a Unifying Theory for Different Components of Diabetic Nephropathy
por: Zheng, Xiaoyi, et al.
Publicado: (2015)

Acute glycemic control in diabetics. How sweet is oprimal? Pro: Sweeter is better in diabetes
por: Bellomo, Rinaldo
Publicado: (2018)

Biomarkers for early diagnosis of diabetic kidney disease: still a long way to go
por: Kumar, Vivek, et al.
Publicado: (2022)

Treatment of type 2 diabetes in chronic kidney disease: a case for linagliptin in the treatment of diabetes in severe renal impairment
por: Scott, David
Publicado: (2013)

Iminosugar antivirals: the therapeutic sweet spot
por: Alonzi, Dominic S., et al.
Publicado: (2017)

Novel anti-inflammatory drugs for the treatment of diabetic kidney disease
por: Heerspink, Hiddo J. L., et al.
Publicado: (2016)

Finding the Sweet Spot: An Interactive Workshop on Diabetes Management in Older Adults
por: Triantafylidis, Laura K., et al.
Publicado: (2019)

The Optimal Glycemic Control in Patients with Diabetes in the ICU: Where Is the Sweet Spot?
por: Hermanides, Jeroen, et al.
Publicado: (2022)

Staying Connected: Transcriptomics in the Search for Novel Diabetic Kidney Disease Treatments
por: Terker, Andrew S., et al.
Publicado: (2021)

Sleep onset is a creative sweet spot
por: Lacaux, Célia, et al.
Publicado: (2021)

Testing for a Sweet Spot in Randomized Trials
por: Redelmeier, Donald A., et al.
Publicado: (2021)

Sugars and Sweet Taste: Addictive or Rewarding?
por: Greenberg, Danielle, et al.
Publicado: (2021)

Sweet Dreams for Better Metabolic Health
por: Xue, Pei, et al.
Publicado: (2023)

Finding the Sweet Spot for Breast Cancer Detection
por: Parasar, Bibudha, et al.
Publicado: (2020)

NICE-SUGAR: the end of a sweet dream?
por: Preiser, Jean-Charles
Publicado: (2009)

Adenine crosses the biomarker bridge: from ‘omics to treatment in diabetic kidney disease
por: Drexler, Yelena, et al.
Publicado: (2023)

Dual therapy and diabetic kidney disease
por: Desai, T.
Publicado: (2015)

Impact of empagliflozin on diabetic kidney disease
por: Koya, Daisuke
Publicado: (2017)

Diabetic Kidney Disease: The “Silent” Majority?
por: Yau, Amy, et al.
Publicado: (2021)

Finding the “Sweet Spot”: Sharing the decision-making in ADHD treatment selection
por: Tan, Daniel, et al.
Publicado: (2022)

Is There a Sweet Spot of Added Sugar Consumption for Cardiovascular Disease Prevention?
por: Janzi, Suzanne, et al.
Publicado: (2022)

Sweet and Sour β-Cells: ROS and Hif1α Induce Warburg-Like Lactate Production During Type 2 Diabetes
por: Cantley, James, et al.
Publicado: (2013)

Beyond the Glomerulus—Kidney Tubule Markers and Diabetic Kidney Disease Progression
por: Bullen, Alexander L., et al.
Publicado: (2021)

A Sweet New Role for Ubiquitin-Specific Protease 2 in Controlling Hepatic Gluconeogenesis
por: Finck, Brian N.
Publicado: (2012)

Linking Klotho, Nrf2, MAP kinases and aging
por: Balasubramanian, Priya, et al.
Publicado: (2010)

Sweet and Low: Measuring Brain Glucose During Hypoglycemia
por: Seaquist, Elizabeth R., et al.
Publicado: (2012)

Exome sequencing: the sweet spot before whole genomes
por: Teer, Jamie K., et al.
Publicado: (2010)

Editorial: Carbohydrates: The Yet to be Tasted Sweet Spot of Immunity
por: Coombe, Deirdre R., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_9ib6u0fotfra8ut519lgddjor7